IMS Health Holdings Inc

IMS Health — Q1 2016 Earnings Presentation

15 slides from IMS Health's earnings presentation, May 3, 2016

  1. Slide 1: First Quarter 2016 Earnings Call

    First Quarter 2016 Earnings Call May 3, 2016

  2. Slide 2: Forward-looking statements

    This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements reflect, among other things, the Company’s current expectations and an

  3. Slide 3: Important Information About the Transaction and Where to Find It

    Important Information About the Transaction and Where to Find It In connection with the proposed transaction, IMS Health and Quintiles will be filing documents with the Securities and Exchange Commission (“SEC”), including the filing by Quintiles of a registration statement on Form S-4, and Quintile

  4. Slide 4: First Quarter 2016 Overview

    First Quarter 2016 Overview Agreement to merge with IMS Health in all-stock transaction to create Quintiles IMS, an industry-leading information and technology-enabled healthcare services provider 8.4% constant currency service revenue growth 23.6% diluted adjusted earnings per share growth Net new

  5. Slide 5: Financial Highlights and Other Metrics

    Financial Highlights and Other Metrics First Quarter 2016 Highlights 8.4% constant currency service revenue growth and 7.6% at actual exchange rates 12.6% PD constant currency service revenue growth and 11.7% at actual exchange rates 200 basis points of expansion in adjusted income from operations m

  6. Slide 6: Segment Performance

    Segment Performance Service Revenues and Income from Operations $ Millions Product Development Integrated Healthcare Services Certain costs are not allocated to the Company’s segments and are reported as general corporate and unallocated expenses. These costs primarily consist of share-based compens

  7. Slide 7: Full Year 2016 Guidance

    Full Year 2016 Guidance Constant currency service revenue growth range of 7.0% to 8.5% Diluted adjusted earnings per share range of $3.70 to $3.85 – growth of 11.1% to 15.6% compared to 20151 Annual effective income tax rate of approximately 29% This financial guidance does not reflect the impact of

  8. Slide 8: Summary and Recognitions during the quarter

    Agreement to merge with IMS Health in all-stock transaction to create Quintiles IMS, an industry-leading information and technology-enabled healthcare services provider 8.4% constant currency revenue growth 23.6% diluted adjusted earnings per share growth $12 billion of diversified backlog Cash flow

  9. Slide 9: Supplemental Information

    Supplemental Information Constant Currency Reconciliation Contractual Revenue Currency Mix and Foreign Exchange Analysis Income Statement Non-GAAP Reconciliation Adjusted EBITDA Reconciliation Adjusted Net Income and EPS Reconciliation Non-GAAP 2016 Guidance Reconciliation

  10. Slide 10: 2016 Constant Currency Reconciliation

    The exchange rate impacts on service revenues equals the current period service revenues at actual rates less the current period service revenues for foreign currency denominated contracts recalculated at the prior period exchange rates. The exchange rate impacts on expenses equals the current perio

  11. Slide 11: Contractual Revenue Currency Mix and Foreign Exchange Analysis

    1 Other includes a mix of more than 40 currencies. Contractual Revenue Currency Mix and Foreign Exchange Analysis

  12. Slide 12: Income Statement GAAP – Non-GAAP Reconciliation

    1 Change in estimated fair value of contingent consideration on business combinations. 2 Reflects the portion of Q2 Solutions’ after-tax non-GAAP adjustments attributable to the minority interest partner. Note: Totals may not sum due to rounding; percentages are calculated from the actual results ro

  13. Slide 13: Reconciliation to Non-GAAP Adjusted EBITDA

    Reconciliation of Net Income Attributable to Quintiles to Non-GAAP Adjusted EBITDA 1 Change in estimated fair value of contingent consideration on business combinations. Note: Totals may not sum due to rounding; percentages are calculated from the actual results rounded to the nearest thousand.

  14. Slide 14: Reconciliation to Non-GAAP Adjusted Net Income and Diluted Adjusted EPS

    Reconciliation of Net Income Attributable to Quintiles to Non-GAAP Adjusted Net Income and Diluted Adjusted EPS 1 EPS is represented in whole dollars. 2 Change in estimated fair value of contingent consideration on business combinations. 3 Reflects the portion of Q2 Solutions’ after-tax non-GAAP adj

  15. Slide 15: Non-GAAP Full Year 2016 Guidance Reconciliation

    Non-GAAP Full Year 2016 Guidance Reconciliation 1 Restructuring costs are adjusted for the portion attributable to the minority interest partner in Q2 Solutions and are tax effected at approximately 30.0%. Note: Totals may not sum due to rounding.

IMS Health Holdings — Q1 2016 Earnings Presentation on 6ix